{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:55:56Z","timestamp":1785858956785,"version":"3.56.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>\n                    Haloperidol (HAL) was developed in 1958 for the treatment of schizophrenia and is classified as a typical antipsychotic drug (APD). Effective in treating positive symptoms of schizophrenia, it does not treat negative symptoms and produces extrapyramidal motor side-effects. Atypical APDs like clozapine treat both positive and negative symptoms of schizophrenia, have reduced extrapyramidal motor side-effects and possess other clinical advantages. This study used a drug discrimination assay to allow a direct comparison between the subjective effects of HAL and other APDs. Eleven C57BL\/6 mice were trained to discriminate 0.05 mg\/kg HAL from the vehicle in a two-lever drug discrimination task. The HAL generalization curve (0.001563\u20130.2 mg\/kg) yielded an ED\n                    <jats:sub>50<\/jats:sub>\n                    =0.0024 mg\/kg (95% confidence interval: 0.0012\u20130.0048 mg\/kg). The typical APD chlorpromazine produced full substitution at 4.0 mg\/kg with 82.7% drug-lever responding (%DLR) with significant rate suppression and partial substitution (73.9% DLR) at 1.0 mg\/kg with no rate suppression. The atypical APD clozapine produced partial substitution at 2.5 mg\/kg (64.8% DLR) with significant rate suppression. The atypical APD amisulpride failed to substitute for HAL with a maximum %DLR of 57.9% at 40 mg\/kg with no rate suppression. The atypical APD aripiprazole partially substituted with a maximum of 75.9% DLR at 1.25 mg\/kg with significant rate suppression. These results demonstrate that HAL can be trained as a discriminative stimulus in C57BL\/6 mice, and its discriminative cue appears to be unique and distinct from that of atypical APDs.\n                  <\/jats:p>","DOI":"10.1097\/fbp.0000000000000487","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:20:34Z","timestamp":1557159634000},"page":"521-528","source":"Crossref","is-referenced-by-count":2,"title":["Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL\/6 mice"],"prefix":"10.1097","volume":"30","author":[{"given":"Timothy J.","family":"Donahue","sequence":"first","affiliation":[{"name":"Department of Psychology, Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Psychology, Virginia Union University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Hillhouse","sequence":"additional","affiliation":[{"name":"Department of Psychology, Weber State University, Ogden, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliseu O.","family":"De Oliveira","sequence":"additional","affiliation":[{"name":"Logos Biosciences, LLC, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Porter","sequence":"additional","affiliation":[{"name":"Department of Psychology, Virginia Commonwealth University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230910","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","article-title":"Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo.","volume":"205","author":"Abbas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R2-20230910","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/0024-3205(85)90028-1","article-title":"A comparison between dopamine-stimulated adenylate cyclase and 3-H-SCH 23390 binding in rat striatum.","volume":"25","author":"Andersen","year":"1985","journal-title":"Life Sci"},{"key":"R3-20230910","first-page":"544","article-title":"The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.","volume":"202","author":"Arnold","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"R4-20230910","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence.","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"R5-20230910","first-page":"625","article-title":"Forty years of antipsychotic Drug research \u2013 from haloperidol to paliperidone \u2013 with Dr. Paul Janssen.","volume":"57","author":"Awouters","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 1)","key":"R6-20230910","first-page":"14","article-title":"Haloperidol update: 1975","volume":"69","author":"Ayd","year":"1976","journal-title":"Proc R Soc Med"},{"key":"R7-20230910","first-page":"243","article-title":"Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.","volume":"8","author":"Baker","year":"1997","journal-title":"Behav Pharmacol"},{"key":"R8-20230910","article-title":"Assessment of learning and memory using the autoshaping of operant responding in mice.","author":"Barrett","year":"2004","journal-title":"Curr Protoc Neurosci"},{"key":"R9-20230910","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00422558","article-title":"Effects of chlorpromazine and three metabolites on behavioral responses in rats.","volume":"34","author":"Barry","year":"1974","journal-title":"Psychopharmacologia"},{"key":"R10-20230910","first-page":"113","article-title":"Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats.","volume":"8","author":"Bevins","year":"1997","journal-title":"Behav Pharmacol"},{"key":"R12-20230910","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine.","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R13-20230910","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis.","volume":"78","author":"Carbon","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R14-20230910","first-page":"566","article-title":"Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.","volume":"28","author":"Cohen","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R15-20230910","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0091-3057(99)00047-7","article-title":"Drug discrimination in neurobiology.","volume":"64","author":"Colpaert","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"R16-20230910","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00421388","article-title":"Theoretical and methodological considerations on drug discrimination learning.","volume":"46","author":"Colpaert","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"R17-20230910","first-page":"391","article-title":"Discriminative stimulus properties of antidepressant agents: a review.","volume":"14","author":"Dekeyne","year":"2003","journal-title":"Behav Pharmacol"},{"key":"R18-20230910","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1007\/s00213-017-4738-y","article-title":"Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL\/6 mice.","volume":"234","author":"Donahue","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"R19-20230910","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00426467","article-title":"Inter-animal olfactory cues in operant drug discrimination procedures in rats.","volume":"73","author":"Extance","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-20230910","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002130050643","article-title":"Discriminative stimulus properties of the dopamine D3 antagonist PNU-99194A.","volume":"138","author":"Franklin","year":"1998","journal-title":"Psychopharmacology"},{"key":"R21-20230910","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0091-3057(78)90310-6","article-title":"Discriminative stimulus properties of clozapine and chlorpromazine.","volume":"8","author":"Goas","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"R23-20230910","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(99)00079-9","article-title":"Discriminative stimulus properties of antipsychotics.","volume":"64","author":"Goudie","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"R26-20230910","first-page":"1637","article-title":"Further evidence for muscarinic antagonism as clozapine\u2019s discriminative stimulus.","volume":"20","author":"Kelley","year":"1997","journal-title":"Soc Neurosci"},{"key":"R27-20230910","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1471-4159.1987.tb04139.x","article-title":"D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H] N-methylspiperone binding.","volume":"48","author":"Lyon","year":"1987","journal-title":"J Neurochem"},{"key":"R28-20230910","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ddr.430180106","article-title":"Discriminative stimulus properties of haloperidol.","volume":"18","author":"McElroy","year":"1989","journal-title":"Drug Dev Res"},{"key":"R29-20230910","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.fbp.0000181592.63125.bc","article-title":"Dissimilar effects of subchronic clozapine and haloperidol on operant lever pressing in C57BL\/6J, BALB\/cJ, and LP\/J mice.","volume":"16","author":"McKerchar","year":"2005","journal-title":"Behav Pharmacol"},{"key":"R30-20230910","first-page":"853","article-title":"Improving the treatment of schizophrenia: focus on serotonin (5-HT1A) receptors.","volume":"295","author":"Millan","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-20230910","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008877-199605000-00007","article-title":"Contribution of individual differences to discriminative stimulus, antinociceptive and rate-decreasing effects of opioids: importance of the drug\u2019s relative intrinsic efficacy at the mu receptor.","volume":"7","author":"Morgan","year":"1996","journal-title":"Behav Pharmacol"},{"key":"R33-20230910","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0091-3057(88)90275-4","article-title":"Rats that acquire a THC discrimination more rapidly are more sensitive to THC and faster in reaching operant criteria.","volume":"29","author":"O\u2019Neal","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"R34-20230910","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00449130","article-title":"Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.","volume":"76","author":"Overton","year":"1982","journal-title":"Psychopharmacology"},{"key":"R36-20230910","first-page":"73","article-title":"Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2\/D3 dopamine receptor antagonist activity and limbic selectivity.","volume":"280","author":"Perrault","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R37-20230910","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00213-005-2147-0","article-title":"Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL\/6 mice.","volume":"180","author":"Philibin","year":"2005","journal-title":"Psychopharmacology"},{"key":"R38-20230910","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-008-1385-3","article-title":"Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL\/6 mice: role of 5-HT (2A) serotonergic and alpha (1) adrenergic antagonism.","volume":"203","author":"Philibin","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R40-20230910","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-008-1308-3","article-title":"Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.","volume":"203","author":"Porter","year":"2009","journal-title":"Psychopharmacology"},{"key":"R41-20230910","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/(SICI)1098-2299(199909)48:1<38::AID-DDR5>3.0.CO;2-C","article-title":"Chlorpromazine as a discriminative stimulus in rats: generalization to typical and atypical antipsychotics.","volume":"48","author":"Porter","year":"1999","journal-title":"Drug Dev Res"},{"key":"R42-20230910","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00213-004-1985-5","article-title":"Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.","volume":"178","author":"Porter","year":"2005","journal-title":"Psychopharmacology"},{"key":"R43-20230910","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0b013e32830cd84e","article-title":"A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA\/2 and C57BL\/6 inbred mice.","volume":"19","author":"Porter","year":"2008","journal-title":"Behav Pharmacol"},{"key":"R47-20230910","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.fbp.0000172735.73876.06","article-title":"Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg\/kg clozapine versus 5.0 mg\/kg clozapine versus vehicle in a three-choice drug discrimination task.","volume":"16","author":"Prus","year":"2005","journal-title":"Behav Pharmacol"},{"key":"R48-20230910","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-008-1281-x","article-title":"Drug discrimination and neurochemical studies in alpha7 null mutant mice: tests for the role of nicotinic alpha7 receptors in dopamine release.","volume":"203","author":"Quarta","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"R49-20230910","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(67)90084-2","article-title":"Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.","volume":"2","author":"Ross","year":"1967","journal-title":"Eur J Pharmacol"},{"key":"R51-20230910","first-page":"1403","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.","volume":"268","author":"Roth","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R52-20230910","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02311185","article-title":"D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.","volume":"120","author":"Roth","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"R53-20230910","first-page":"83","article-title":"Neurochemical characteristics of amisulpride, an atypical dopamine D2\/D3 receptor antagonist with both presynaptic and limbic selectivity.","volume":"280","author":"Schoemaker","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R54-20230910","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"R55-20230910","first-page":"440","article-title":"Haloperidol: a quarter century of experience.","volume":"44","author":"Settle","year":"1983","journal-title":"J Clin Psychiatry"},{"key":"R56-20230910","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"R57-20230910","first-page":"224","article-title":"Localization and function of the D3 dopamine receptor.","volume":"42","author":"Sokoloff","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"R58-20230910","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00408342","article-title":"Differential responses based on the physiological consequences of pharmacological agents.","volume":"3","author":"Stewart","year":"1962","journal-title":"Psychopharmacologia"},{"key":"R59-20230910","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/FBP.0b013e328349ab37","article-title":"Role of training dose in drug discrimination: a review.","volume":"22","author":"Stolerman","year":"2011","journal-title":"Behav Pharmacol"},{"key":"R60-20230910","first-page":"273","article-title":"An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response.","volume":"9","author":"Vanover","year":"1998","journal-title":"Behav Pharmacol"},{"key":"R61-20230910","first-page":"720","article-title":"Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences.","volume":"27","author":"Wainscott","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R62-20230910","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3758\/BF03334149","article-title":"Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol.","volume":"31","author":"Wiley","year":"1993","journal-title":"Bull Psychon Soc"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FBP.0000000000000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:59:38Z","timestamp":1785855578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FBP.0000000000000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000487","relation":{},"ISSN":["0955-8810"],"issn-type":[{"value":"0955-8810","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}